• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《综合精神医学》 >How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China

How psychiatrists coordinate treatment for COVID-19: a retrospective study and experience from China

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background Patients with C0VID-19 are at high risk of developing mental health problems;however,the prevalence and management of mental disorders and how psychiatrists coordinate the treatment are unclear.Aims We aimed to investigate the mental health problems of patients infected with C0VID-19 and to identify the role of psychiatrists in the clinical treatment team during the pandemic.We also share the experience of psychiatric consultations of patients with COVID-19 in Shanghai,China.Methods We analysed data from the psychiatric medical records of 329 patients with COVID-19 in the Shanghai Public Health Clinical Center from 20 January to 8 March 2020.We collected information including sociodemographic characteristics,whether patients received psychiatric consultation,mental health symptoms,psychiatric diagnoses,psychiatric treatments and severity level of COVID-19.Results Psychiatric consultations were received by 84(25.5%)patients with COVID-19.The most common symptoms of mental health problems were sleep disorders(75%),anxiety(58.3%)and depressive symptoms(11.9%).The psychiatric consultation rate was highest in critically ill patients(69.2%),with affective symptoms or disturbed behaviour as their main mental health problems.Psychiatric diagnoses for patients who received consultation included acute stress reaction(39.3%),sleep disorders(33.3%),anxiety(15.5%),depression(7.1%)and delirium(4.8%).In terms of psychiatric treatments,86.9%of patients who received psychiatric consultation were treated with psychotropic medications,including non-benzodiazepine sedative-hypnotic agents(54.8%),antidepressants(26.2%),benzodiazepines(22.6%)and antipsychotics(10.7%).Among the 76 patients who were discharged from the hospital,79%had recovered from mental health problems and were not prescribed any psychotropic medications.The symptoms of the remaining 21%of patients had improved and they were prescribed medications to continue the treatment.Conclusions This is the first study to report psychiatric consultations for patients with COVID-19.Our study indicated that a considerable proportion of patients with COVID-19,especially critically ill cases,experienced mental health problems.Given the remarkable effect of psychiatric treatments,we recommend that psychiatrists be timely and actively involved in the treatment of COVID-19.

著录项

  • 来源
    《综合精神医学》 |2020年第4期|174-178|共5页
  • 作者

    Ling Yue; Jingyi Wang; Mingliang Ju; Yi Zhu; Lianghu Chen; Lin Shi; Bohai Shi; Jun Chen; Yifeng Shen;

  • 作者单位

    Department of Psychiatry Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center Shanghai China;

    Department of Social Medicine School of Public Health Fudan University Shanghai China;

    Department of Population Science and Experimental Medicine University College London London UK;

    Department of Psychiatry Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center Shanghai China;

    Department of Psychiatry Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center Shanghai China;

    Department of Psychiatry Nanhui Mental Health Center of Pudong New Area Shanghai China;

    Department of General Adult Psychiatry Xuhui District Mental Health Center Shanghai China;

    Department of Psychiatry Hongkou District Mental Health Center Shanghai China;

    Department of Psychiatry Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center Shanghai China;

    Department of Psychiatry Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Mental Health Center Shanghai China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号